The shelf

Reader’s guides

Each title summarizes the published record with every claim cited. Catalog titles are printed and shipped to members; the references below them are free to read and print. Corrections and status updates are logged under What changed.

Catalog titles

Metabolic

The GLP-1 era: weight and blood sugar

4 titles

Newport Peptide SocietyCompounded TirzepatideMetabolicPrinted guide

Compounded Tirzepatide

A guide to the dual GIP / GLP-1 receptor agonist

First edition · September 2026

Newport Peptide SocietyRetatrutideMetabolicPrinted guide

Retatrutide

A guide to the triple GIP / GLP-1 / glucagon agonist

First edition · September 2026

Newport Peptide SocietyCagrilintide / SemaglutideMetabolicPrinted guide

Cagrilintide / Semaglutide

A guide to CagriSema: an approved drug paired with an investigational one, a decision due from the FDA this year, and a blend vial that is neither

First edition · September 2026

Newport Peptide SocietySemaglutideMetabolicPrinted guide

Semaglutide

A guide to the drug in Ozempic and Wegovy: the most-studied peptide in the world, a pill since 2025, a generic in Canada since June, and a vial market the FDA spent 2026 shutting down

First edition · September 2026

Growth hormone

Releasers, not the hormone itself

3 titles

Newport Peptide SocietyCJC-1295 / IpamorelinGrowth hormonePrinted guide

CJC-1295 / Ipamorelin

A guide to the growth hormone stack: two abandoned drugs, one blend vial no study has tested, and a compounding ban that sellers ignore

First edition · September 2026

Newport Peptide SocietyTesamorelinGrowth hormonePrinted guide

Tesamorelin

A guide to the only approved growth hormone releaser: what the label says, what the trials measured, and why the prescription is legal when the vial usually is not

First edition · September 2026

Newport Peptide SocietySermorelinGrowth hormonePrinted guide

Sermorelin

A guide to the clinic classic: a drug approved for children and then withdrawn, a molecule pharmacies may still compound, and thirty-year-old trials that measured hormones rather than outcomes

First edition · September 2026

Healing

Injury, gut, and recovery

2 titles

Newport Peptide SocietyBPC-157HealingPrinted guide

BPC-157

A guide to the healing peptide: a thousand animal studies, thirty human subjects, and a rule change in progress

First edition · September 2026

Newport Peptide SocietyBPC-157 / TB-500HealingPrinted guide

BPC-157 / TB-500

A guide to the healing blend vendors call the Wolverine stack: two peptides sold on the same mechanism, one with thin human evidence and one with none, never tested together

First edition · September 2026

Skin

Skin, hair, and tanning

4 titles

Newport Peptide SocietyGHK-CuSkinPrinted guide

GHK-Cu

A guide to the copper peptide: a skin-cream ingredient with fifty years of small studies, and an injection with none

First edition · September 2026

Newport Peptide SocietyGLOWSkinPrinted guide

GLOW

A guide to the three-peptide blend vial: a skin peptide injected in bulk, two healing peptides along for the ride, and no study of any of it together

First edition · September 2026

Newport Peptide SocietyMelanotan IISkinPrinted guide

Melanotan II

A guide to the tanning peptide: it works, no regulator has ever approved it, and the published cases are about moles, kidneys, and emergency rooms

First edition · September 2026

Newport Peptide SocietyKLOWSkinPrinted guide

KLOW

A guide to the four-peptide blend vial: GLOW with a gut-inflammation tripeptide added, sold on a mouse colitis model, and a July 2026 committee vote that changed nothing yet

First edition · September 2026

Sexual health

Desire and function

1 title

Newport Peptide SocietyPT-141Sexual healthPrinted guide

PT-141

A guide to bremelanotide: an approved drug for women's sexual desire, sold by the vial to men, with a modest effect, a lot of nausea, and a blood-pressure warning on its label

First edition · September 2026

Longevity

Energy, aging, and cognition

4 titles

Newport Peptide SocietyNAD+LongevityPrinted guide

NAD+

A guide to the drip and the shot: a molecule every cell makes, sold by the milligram at med spas, with real chemistry, small trials, and no outcome anyone has measured

First edition · September 2026

Newport Peptide SocietyMOTS-cLongevityPrinted guide

MOTS-c

A guide to the mitochondrial peptide: an exercise mimic in mice, a discontinued analog in twenty people, and a July 2026 committee vote the FDA's own staff argued against

First edition · September 2026

Newport Peptide SocietyEpitalonLongevityPrinted guide

Epitalon

A guide to the pineal tetrapeptide: forty years of work from one St. Petersburg institute, a telomerase result in a dish, and a July 2026 committee vote on an indication no study has tested

First edition · September 2026

Newport Peptide SocietySemaxLongevityPrinted guide

Semax

A guide to the Russian nasal drops sold as a nootropic: thirty years of use in one country, no controlled trial anyone outside it can read, and a July 2026 committee vote the FDA's own reviewers argued against

First edition · September 2026

Free references